NASDAQ:GH

Guardant Health Stock Insider Trading

Healthcare > Medical - Diagnostics & Research

Buy GH

*Your capital is at risk

$158.40

-1.65 (-1.03%)

At Close: Jul 13, 2026

Guardant Health Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -80.57. In total, the insiders bought 792.05K and sold 321.98K GH shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-80.57
● Buy	792.05K shares
● Sell	321.98K shares
80% Buy Activity Strong Negative Correlation
Buy Signal Low Confidence Jul 01, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -80.57. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (80% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Jul 01, 2026 Buy	Common Stock M-Exempt	Kalia Kumud Chief Information Officer	Officer	1 361 Value: $232.4K
Jul 01, 2026 Buy	Common Stock M-Exempt	Kalia Kumud Chief Information Officer	Officer	1 084 Value: $185.1K
Jul 01, 2026 Buy	Restricted Stock Units M-Exempt	Kalia Kumud Chief Information Officer	Officer	1 994 Value: $340.5K
Jul 01, 2026 Buy	Restricted Stock Units M-Exempt	Freeman Chris Chief Commercial Officer	Officer	2 526 Value: $431.4K
Jul 01, 2026 Buy	Common Stock M-Exempt	Freeman Chris Chief Commercial Officer	Officer	1 667 Value: $284.7K
Jul 01, 2026 Buy	Restricted Stock Units M-Exempt	Talasaz Amirali Co-chief Executive Officer	CEO / President	9 715 Value: $1.66M
Jul 01, 2026 Buy	Restricted Stock Units M-Exempt	Saia John G. Chief Legal Officer	Officer	1 497 Value: $255.6K
Jul 01, 2026 Buy	Common Stock M-Exempt	Eltoukhy Helmy Co-chief Executive Officer	CEO / President	9 715 Value: $1.66M
Jul 01, 2026 Buy	Common Stock M-Exempt	Bell Michael Brian Chief Financial Officer	C-Suite Officer	2 084 Value: $355.9K
Jul 01, 2026 Sell	Common Stock F-InKind	Monroe Terilyn J. Chief People Officer	Officer	2 099 Value: $358.4K
Jul 01, 2026 Buy	Common Stock M-Exempt	Monroe Terilyn J. Chief People Officer	Officer	2 659 Value: $454.1K
Jul 01, 2026 Buy	Restricted Stock Units M-Exempt	Freeman Chris Chief Commercial Officer	Officer	1 928 Value: $329.2K
Jul 01, 2026 Buy	Restricted Stock Units M-Exempt	Kalia Kumud Chief Information Officer	Officer	1 084 Value: $185.1K
Jul 01, 2026 Buy	Restricted Stock Units M-Exempt	Monroe Terilyn J. Chief People Officer	Officer	1 361 Value: $232.4K
Jul 01, 2026 Buy	Restricted Stock Units M-Exempt	Monroe Terilyn J. Chief People Officer	Officer	2 659 Value: $454.1K
Jul 01, 2026 Buy	Restricted Stock Units M-Exempt	Saia John G. Chief Legal Officer	Officer	974 Value: $166.3K
Jul 01, 2026 Buy	Restricted Stock Units M-Exempt	Eltoukhy Helmy Co-chief Executive Officer	CEO / President	23 997 Value: $4.10M
Jul 01, 2026 Buy	Common Stock M-Exempt	Bell Michael Brian Chief Financial Officer	C-Suite Officer	1 870 Value: $319.3K
Jul 01, 2026 Sell	Common Stock F-InKind	Bell Michael Brian Chief Financial Officer	C-Suite Officer	3 914 Value: $668.4K
Jul 01, 2026 Buy	Restricted Stock Units M-Exempt	Bell Michael Brian Chief Financial Officer	C-Suite Officer	3 324 Value: $567.6K
Jul 01, 2026 Buy	Restricted Stock Units M-Exempt	Bell Michael Brian Chief Financial Officer	C-Suite Officer	2 084 Value: $355.9K
Jul 01, 2026 Buy	Common Stock M-Exempt	Eltoukhy Helmy Co-chief Executive Officer	CEO / President	23 997 Value: $4.10M
Jul 01, 2026 Buy	Restricted Stock Units M-Exempt	Saia John G. Chief Legal Officer	Officer	2 925 Value: $499.5K
Jul 01, 2026 Buy	Restricted Stock Units M-Exempt	Saia John G. Chief Legal Officer	Officer	1 667 Value: $284.7K
Jul 01, 2026 Sell	Common Stock F-InKind	Talasaz Amirali Co-chief Executive Officer	CEO / President	17 086 Value: $2.92M

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT GUARDANT HEALTH INC.

Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a clinical-genomic liquid biopsy dataset of advanced cancer patients. It is also developing LUNAR-2 test fo...

Read Full Profile Here